Literature DB >> 10353857

TT virus infection in patients with hepatitis C: frequency, persistence, and sequence heterogeneity.

W L Irving1, J K Ball, S Berridge, R Curran, A M Grabowska, C L Jameson, K R Neal, S D Ryder, B J Thomson.   

Abstract

TT virus (TTV) was recently identified in the serum of a patient with hepatitis. The role of TTV in liver disease has not been established. Three polymerase chain reaction (PCR) protocols were used to detect TTV DNA in sera of persons infected with hepatitis C virus (HCV) and in blood donors. Sera from 11.5% of HCV-infected patients and 7.7% of blood donors were positive by protocols 1 or 2. In contrast, 48.7% and 57.7% of sera, respectively, were positive when tested by protocol 3. There was no difference in the severity of hepatitis in persons coinfected with TTV and HCV when compared with those infected with HCV alone, regardless of which TTV PCR protocol was used. TTV DNA persisted in serum samples taken up to 6 years apart in individual patients. Sequence analysis indicated that most viral sequences were distinct between patients, and there was evidence of genetic heterogeneity and viral evolution within individuals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10353857     DOI: 10.1086/314825

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Sequestration of TT virus of restricted genotypes in peripheral blood mononuclear cells.

Authors:  H Okamoto; M Takahashi; N Kato; M Fukuda; A Tawara; S Fukuda; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Isolation of multiple TT virus genotypes from spleen biopsy tissue from a Hodgkin's disease patient: genome reorganization and diversity in the hypervariable region.

Authors:  Ilijas Jelcic; Agnes Hotz-Wagenblatt; Andreas Hunziker; Harald Zur Hausen; Ethel-Michele de Villiers
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  Human circovirus TT virus genotype 6 expresses six proteins following transfection of a full-length clone.

Authors:  Jianming Qiu; Laura Kakkola; Fang Cheng; Chaoyang Ye; Maria Söderlund-Venermo; Klaus Hedman; David J Pintel
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  High prevalence of TT virus (TTV) and TTV-like minivirus in cervical swabs.

Authors:  C Fornai; F Maggi; M L Vatteroni; M Pistello; M Bendinelli
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

5.  Coinfection with multiple TT virus strains belonging to different genotypes is a common event in healthy Brazilian adults.

Authors:  C Niel; F L Saback; E Lampe
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

Review 6.  Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans.

Authors:  M Bendinelli; M Pistello; F Maggi; C Fornai; G Freer; M L Vatteroni
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

7.  Torque teno virus: its prevalence and isotypes in North India.

Authors:  Mohammad Irshad; Shiwani Singh; Khushboo Irshad; Sanjay-Kumar Agarwal; Yogendra-Kumar Joshi
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

8.  Response of TT virus to IFN plus ribavirin treatment in patients with chronic hepatitis C.

Authors:  Javier Moreno; Gloria Moraleda; Rafael Barcena; Mluisa Mateos; Santos del Campo
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

9.  TTV and HPV co-infection in cervical smears of patients with cervical lesions.

Authors:  Martina Saláková; Vratislav Nemecek; Ruth Tachezy
Journal:  BMC Infect Dis       Date:  2009-07-28       Impact factor: 3.090

10.  Viral communities associated with human pericardial fluids in idiopathic pericarditis.

Authors:  Laura Fancello; Sonia Monteil; Nikolay Popgeorgiev; Romain Rivet; Frédérique Gouriet; Pierre-Edouard Fournier; Didier Raoult; Christelle Desnues
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.